Centogene Company
CENTOGENE is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for Patients.
Technology:
Pregnancy biomarkers, Biomarkers of Female Cancers
Industry:
Mitochondrial Genetics
Headquarters:
Germany
Founded Date:
2016
Funding Status:
Series A
Investors Number:
4
Total Funding:
$29 M
Estimated Revenue:
$50M to $100M
Last Funding Type:
Grant
Register and Claim Ownership